Patient-Reported Physical Functioning May Predict HCT Outcomes
the ONA take:
Patient-reported outcomes have the potential to improve prognostication in patients undergoing hematopoietic stem cell transplantation (HSCT), a new study published online ahead of print in the journal Cancer has shown.
Although patient-reported outcomes predict mortality in multiple cancers, there are few studies assessing their value in HSCT.
Therefore, researchers sought to determine whether pre-HSCT patient-reported outcomes, particularly physical health, predict survival among patients undergoing autologous or allogeneic HSCT.
For the analysis, the researchers analyzed data from pre-HSCT patient-reported outcomes that were reported by 336 allogeneic and 310 autolgous HSCT recipients. Participants were enrolled in a larger study that included a broad representation of patients who underwent HSCT in the United States.
Results showed that physical functioning independently predicted overall mortality among allogeneic HSCT recipients. Researchers found that early post-HSCT declines in physical functioning were associated with higher overall and treatment-related mortality.
The authors recommend that patient-reported outcomes be routinely collected prior to HSCT, and that patient-reported outcomes be considered for incorporation into risk adjustment for quality reporting.
Patient-reported outcomes have the potential to improve prognostication in patients undergoing hematopoietic stem cell transplantation.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|